You are here
Publications: 2014 - 2019
Bilcke J, Chapman R, Atchison C, Cromer D, Johnson H, Willem L, Cox M, Edmunds WJ, Jit M. 2015 Jan 26. Quantifying parameter and structural uncertainty of dynamic disease transmission models using MCMC: an application to rotavirus vaccination in England & Wales. Med Decis Making, 2015 Jul;35(5):633-47.
Jit M, Brisson M, Lapise J-F, Choi YH. 2015 Jan 7. Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model.. BMJ, 2015;350:g7584.
Jit M, Mibei Walter. 2015 Jul 31. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: a critical review. Vaccine, 33(32):3788-94.
Taylor E, Atkins K, Medlock J, Li M, Chapman G, Galvani A. 2015 Jun 17. Cross-cultural household influence on vaccination decision. Med Decis Making, 36(7):844-53.
Flasche S, van Hoek AJ,Goldblatt D, Edmunds WJ, O’Brien KL, Scott JAG, Miller E. 2015 Jun 9. The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity. PLoS Med, 12(6).
Atkins KE, Wenzel NS, Ndeffo-Mbah M, Altice FL, Townsend JP, Galvani AP. 2015 Mar 16. Under-reporting and case fatality estimates for emerging epidemics. BMJ, 2015;350:h1115.
Wilson R. J, Paterson P, Jarrett C, Larson H. 2015 Nov 25. Understanding factors infleuncing vaccination acceptance during pregnancy globally: A literature review. Vaccine, 33(47):6420-9.
Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A, Funk S, Kucharski A, Ilunga BK, Edmunds WJ, Piot P, Baguelin M, Muyembe Tamfum JJ. 2015 Nov 3. Ebola virus disease in the Democratic Republic of the Congo, 1976-2014. Elife, 4. pii: e09015.
Baguelin M, Camacho A, Flasche S, Edmunds WJ. 2015 Oct 13. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study. BMC Med, 13:236.
Thorrington D, Jit M, Eames K. 2015 Oct 5. Targeted vaccination in healthy school children - can primary school vaccination alone control influenza? Vaccine, 33(41):5415-5424.
Atkins K, Pandey A, Wenzel N, Skrip L, Yamin D, Nyenswah T, Falla M, Bawo L, Medlock M, Altice F, Townsend J, Ndeffo-Mbah M, Galvani A. 2016 Apr. Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. Am J Trop Med Hyg, 94(4):833-9.
Fitzpatrick M, Wenzel N , Scarpino S, Althouse B, Atkins K, Galvani Alison, Townsend J. 2016 Apr 14. Cost-effectiveness of next-generation vaccines: the case of pertussis.. Vaccine, 34(29):3405-11.
Xiao X, van Hoek A, Kenward M, Melegaro A, Jit M. 2016 Dec. Clustering of contacts relevant to the spread of infectious disease. Epidemics, 17:1-9.
Atkins, K. van Hoek, A J, Watson C, Baguelin, M, Choga L, Patel A, Raj T, Jit M, Griffiths U. 2016 Feb 16. Seasonal influenza vaccination delivery through community pharmacists in England: evaluation of the London pilot.. BMJ Open, 6(2):e009739.
van Hoek A.J., Miller E. 2016 Feb 25. Cost-effectiveness of vaccinating immunocompetent ≥65 year olds with the 13-valent pneumococcal conjugate vaccine in England. PLoS One, 11(2):e0149540.
Atchison C J, Stowe J, Andrews N, Collins D, Allen DJ, Nawaz S, Borwn D, Ramsay M E, Ladhani S. 2016 Jan 15. Rapid Declines in Age Group–Specific Rotavirus Infection and Acute Gastroenteritis Among Vaccinated and Unvaccinated Individuals Within 1 Year of Rotavirus Vaccine Introduction in England and Wales.. J Infect Dis., 213(2):243-9.
Jit M, Hutubessy R. 2016 Jan 30. Methodological challenges to economic evaluations of vaccines: is a common approach still possible?. Appl Health Econ Health Policy, 14(3):245-52.
van Hoek A, Campbell H, Amirthalingam G, Andrews N, Miller E. 2016 Jul. Cost-effectiveness and programmatic benefits of maternal vaccination against pertussis in England.. J Infect, 73(1):28-37.
Li M, Taylor E, Atkins K, Chapman G, Galvani A. 2016 Jul 26. Stimulating Influenza Vaccination via Prosocial Motives. PLOS ONE, 11(7):e0159780.
Atkins K, Fitzpatrick M, Galvani A, Townsend J. 2016 Jun 15. Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. Am J Epidemiol, 183(12):1159-70.
Leite A, Andrews N, Thomas S. 2016 Mar. Near real-time vaccine safety surveillance using leectronic health records - a systematic reviews of the application of statistical methods. Pharmacoepidemiol Drug Saf., 25(3):225-37..
Wilson R, Larson H, Paterson P. 2016 Nov. Understanding factors influencing vaccination acceptance during pregnancy in Hackney, London. The Lancet, 388:S112.
van Kleef E, Deeny S, Jit M, Cookson B, Goldenberg S, Edmunds W et al. 2016 Nov 4. The projected effectiveness of Clostridium difficile vaccination as part of an integrated infection control strategy. Vaccine, 34(46):5562-5570.
Hobbelen P, Stowe J, Amirthalingam G, Miller L, van Hoek A. 2016 Sep. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. J Infect, 73(3):241-53.
Choi Y, Campbell H, Amirthalingam G, van Hoek A, Miller E. 2016 Sep 1. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med, 14(1):121.
Yamin D, Atkins K, Remy V, Galvani A. 2016 Sept - Oct. Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection. Value Health, 19(6):811-819.
Leite A, Andrews N, Thomas S. 2017 Apr. Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf, 26(4):437-445.
Jain A, van Hoek A, Boccia D, Thomas S. 2017 Apr 25. Lower vaccine uptake amongst older individuals living alone: A systematic review and meta-analysis of social determinants of vaccine uptake. Vaccine, 35(18):2315-2328.
Wilson RJ, Chantler T, Lees S, Paterson P, Larson H.. 2017 Aug 10. The patient-healthcare worker relationship: how does it affect patient views towards vaccination during pregnancy?. Research in the Sociology of Health Care, 35: 59-77.
Lemieux-Mellouki P, Drolet M, Jit M, Gingras G, Brisson M. 2017 Dec. Modelling multi-site transmission of the human papillomavirus and its impact on vaccination effectiveness. Epidemics, 21:80-87.
Leite A, Thomas SL, Andrews NJ. 2017 Dec 14. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Vaccine, 35:6885-6892.
Hodgson D, Baguelin M, van Leeuwen E, Panovska-Griffiths J, Ramsay M, Pebody R, Atkins KE. 2017 Feb. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. Lancet Public Health, 2(2):e74-e81.
Leite A, Andrews N, Thomas S. 2017 Feb 3. Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf, 26(4):437-445.
Crocker-Buque T, Edelstein M, Mounier-Jack S. 2017 Jan. Interventions to reduce inequalities in vaccine uptake in children and adolescents aged <19 years: a systematic review. J Epidemiol Community Health, 71(1):87-97.
Thomas S, Walker J, Fenty J, Atkins K, Elliot A, Hughes H et al. 2017 Jan 23. Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted. Vaccine, 35(4):680-686.
Cromer D, van Hoek A, Newall A, Pollard A, Jit M. 2017 Jul 31. Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England. Lancet Public Health, 2(8):e367-e374.
Lin A, Ong K, Hobbelen P, King E, Mesher D, Edmunds W et al. 2017 Mar 1. Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men. Clin Infect Dis, 64(5):580-588.
Kennedy I, van Hoek A, Ribeiro S, Christensen H, Edmunds W, Ramsay M et al. 2017 May 18. Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study. PloS One, 12(5):e0177082.
Piot P, Coltart C, Atkins K. 2017 May 26. Preface: ‘The 2013–2016 West African Ebola epidemic: data, decision-making and disease control’. Philos Trans R Soc Lond B Biol Sci., 372(1721):20170020.
Coltart C, Edmunds W, Atkins K. 2017 May 26. The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity. Philos Trans R Soc Lond B Biol Sci., 372(1721). pii: 20160292.
Mbala P, Baguelin, M., Ngay, I., Rosello, A., Mulembakani, P., Demiris, N., Edmunds, W. J. & Muyembe, J.-J. 2017 May 26. Evaluating the frequency of asymptomatic Ebola virus infection. Philos Trans R Soc Lond B Biol Sci., 372(1721). pii: 20160303.
van Leeuwen E, Klepac P, Thorrington D, Pebody R, Baguelin M. 2017 Nov 20. fluEvidenceSynthesis: An R package for evidence synthesis based analysis of epidemiological outbreaks. PLoS Comput Biol, 13(11):e1005838.
Leite A, Thomas SL, Andrews NJ. 2017 Nov 28. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink? Pharmacoepidemiol Drug Saf, 27(1):25-29.
Jain A, van Hoek A, Walker JL, Mathur R, Smeeth, Thomas SL. 2017 Nov 30. Identifying social factors amongst older individuals in linked electronic health records: An assessment in a population based study. PloS One, 12:e0189038.
Walker JL, Andrews NJ, Mathur R, Smeeth L, Thomas SL. 2017 Oct. Trends in the burden of varicella in UK general practice. Epidemiol Infect, 145(13):2678-2682.
Edwards A, Bedford H, Campbell H, Letley L, Paterson P, Pebody R et al. 2017 Oct 7. Promoting influenza vaccine for children. Practice Nursing, 28(10): 413-418.
Sandmann F, Jit M, Robotham J, Deeny S. 2017 Sep. Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11–2015/16. J Hosp Infect, 97(1):79-85.
Edelstein M, Crocker-Buque T, Tsang C, Eugenio O, Hopson T, Pebody R et al. 2017 Sep 12. Extracting general practice data for timely vaccine coverage estimates: The England experience. Vaccine, 35(38):5110-5114.
Karafillakis E, Larson H. 2017 Sep 5. The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations. Vaccine, 35(37):4840-4850.
Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M. 2017 Sep 8. Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England. BMC Medicine, 15(1): 166.
Mendes D, Mesher D, Pista A, Baguelin M, Jit M. 2018 Apr 1. Understanding differences in cervical cancer incidence in Western Europe: comparing Portugal and England. Eur J Public Health, 28(2):343-347.
Fernandes S, Jit M, Bozzani F, Griffiths U, Scott J, Burchett H. 2018 Apr 19. A bibliometric analysis of systematic reviews on vaccines and immunisation. Vaccine, 36(17):2254-2261.
Walker JL, Andrews NJ, Amirthalingam G, Forbes H, Langan SM, Thomas SL. 2018 Apr 19. Effectiveness of herpes zoster vaccination in an older United Kingdom population. Vaccine, 36: 2371–2377.
Sandmann F, Shallcross L, Adams N, Allen D, Coen P, Jeanes A et al. 2018 Aug 16. Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients. Clin Infect Dis, 67(5):693-700.
Paterson P, Chantler T, Larson H. 2018 Aug 18. Reasons for non-vaccination: Parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England. Vaccine, 36(36):5397-5401.
Crocker-Buque T, Mounier-Jack S. 2018 Dec 6. Vaccination in England: a review of why business as usual is not enough to maintain coverage. BMC Public Health, 18(1).
Opatowski L, Baguelin M, Eggo R. 2018 Feb 15. Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling. PLoS Pathog, 14(2):e1006770.
Thorrington D, Andrews N, Stowe J, Miller E, van Hoek A. 2018 Feb 8. Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control. BMC Medicine, 16(1):13.
Thorrington D, van Rossum L, Knol M, de Melker H, Rümke H, Hak E et al. 2018 Feb 9. Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands. PLoS One, 13(2):e0192640.
Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M.. 2018 Jun. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.. Lancet Infect Dis, 18(6):e204-e213.
Atkins K, Lafferty E, Deeny S, Davies N, Robotham J, Jit M. 2018 Jun. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance. Lancet Infect Dis, 18(6):e204-e213.
Jain A, van Hoek AJ, Walker JL, Forbes HJ, Langan SM, Root A, Smeeth L, Thomas SL. 2018 Jun. Inequalities in zoster disease burden: a population-based cohort study to identify social determinants using linked data from the UK Clinical Practice Research Database.. Br J Dermatol, 178(6):1324-1330.
Atkins K, Flasche S. 2018 Mar. Vaccination to reduce antimicrobial resistance. Lancet Global Health, 6(3):e252.
Sandmann F, Robotham J, Deeny S, Edmunds W, Jit M. 2018 Mar. Estimating the opportunity costs of bed-days. Health Econ, 27(3):592-605.
Paterson P, Schulz W, Utley M, Larson H. 2018 Mar 28. Parents’ Experience and Views of Vaccinating Their Child against Influenza at Primary School and at the General Practice. Int J Environ Res Public Health, 15(4). pii: E622.
Bisset K, Paterson P. 2018 May 11. Strategies for increasing uptake of vaccination in pregnancy in high-income countries: A systematic review. Vaccine, 36(20):2751-2759.
Southern J, Andrews N, Sandu P, Sheppard CL, Waight PA, Fry NK, van Hoek AJ, Miller E. 2018 May 25. Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England.. Plos One, 13(5): e0195799..
Hargreaves S, Nellums LB, Ramsay M, Saliba V, Majeed A, Mounier-Jack S, Friedland JS. 2018 May 5. Who is responsible for the vaccination of migrants in Europe?. Lancet, 391(10132):1752-1754.
Atkins KE, Lipsitch M. 2018 Nov. Can antibotic resistance be reduced by vaccinating against respiratory disease?. Lancet Respiratory Medicine, 6(11):820-821.
Seok J, Heffernan C, Mounier-Jack S, Chantler T. 2018 Nov. Perspectives of vaccinators on the factors affecting uptake of meningococcal ACWY vaccine amongst school leavers in London.. Public Health, 164:128-133.
Flasche S, Atkins KE. 2018 Nov 1. Balancing benefits and risks of antibiotic use. Journal of Infectious Diseases, Volume 218, Issue 9, Pages 1351–1353.
Jain A, Walker J, Mathur R, Forbes H, Langan S, Smeeth L, van Hoek A, Thomas S. 2018 Nov 15. Zoster vaccination inequalities: A population based cohort study using linked data from the UK Clinical Practice Research Datalink. PLOS ONE, 13(11), p.e0207183.
Jit M. 2018 Nov 9. MCDA from a health economics perspective: opportunities and pitfalls of extending economic evaluation to incorporate broader outcomes. Cost Eff Resour Alloc, 16(Suppl 1): 45.
Crocker-Buque T, Edelstein M, Mounier-Jack S. 2018 Oct 22. A process evaluation of how the routine vaccination programme is implemented at GP practices in England. Implementation Science., 13(1).
Sandmann FG, Jit M, Robotham JV, Deeny SR. 2018 Sep. Revisiting the winter burden of acute gastroenteritis on hospital beds in England: change in data collection supports analytical method for previously missing values.. Journal of Hospital Infection, 100(1):115-117..
Munday J, van Hoek A, Edmunds W, Atkins K. 2018 Sep 26. Quantifying the impact of social groups and vaccination on inequalities in infectious diseases using a mathematical model. BMC Medicine, 16(1).
Park M, Jit M, Wu JT. 2018 Sep 5. Cost-benefit analysis of vaccination: a comparative analysis of eight approaches for valuing changes to mortality and morbidity risks. BMC Med, 16(1):139..
Walker JL, Andrews NJ, Atchison CJ, Collins S, Allen DJ, Ramsay ME, Ladhani SN, Thomas SL. 2019 Apr 11. Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis. Vaccine:X, 1:100005.
Luyten J, Bruynzeel L, van Hoek AJ. 2019 Apr 24. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument.. Vaccine, Volume 37, Issue 18, Pages 2494-2501.
Bate J, Baker S, Breuer J, Chisholm JC, Gray J, Hambleton S, Houlton A, Jit M, Lowis S, Makin G, O'Sullivan C, Patel SR, Phillips R, Ransinghe N, Ramsay ME, Skinner R, Wheatley K, Heath PT. 2019 Jan. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Arch Dis Child, 104(1):25-29.
Chantler T, Bell S, Saliba V, Heffernan C, Raj T, Ramsay M et al. 2019 Jan 17. Is partnership the answer? Delivering the national immunisation programme in the new English health system: a mixed methods study. BMC Public Health, 19(1): 83.
Davies NG, Flasche S, Jit M, Atkins KE. 2019 Jan 3. Within-host dynamics shape the coexistence of antibiotic-sensitive and resistant bacteria. Nature Ecology and Evolution, 3:440-449.
Chantler T, Letley L, Paterson P, Yarwood J, Saliba V, Mounier-Jack S. 2019 Jul 24. Optimising informed consent in school-based adolescent vaccination programmes in England: A multiple methods analysis. Vaccine, pii: S0264-410X(19)30969-7.
Andrews N, Stowe J, Thomas SL, Walker JL, Miller E.. 2019 Jul 30. The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England. Vaccine, pii: S0264-410X(19)30967-3.
Bell S, Edelstein M, Zatoński M, Ramsay M, Mounier-Jack S. 2019 Jul 9. I don't think anybody explained to me how it works': qualitative study exploring vaccination and primary health service access and uptake amongst Polish and Romanian communities in England.. BMJ Open, 9(7):e028228.
Minassian C, Williams R, Meeraus WH, Smeeth L, Campbell OMR, Thomas SL. 2019 July. Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database.. Pharmacoepidemiol Drug Saf, 28(7):923-933.
Chantler T, Karafillakis E, Wilson J. 2019 Jun. Vaccination: Is There a Place for Penalties for Non-compliance?. Appl Health Econ Health Policy, 17(3):265-271.
Crocker-Buque T, Mohan K, Ramsay M, Edelstein M, Mounier-Jack S. 2019 Jun 14. What is the cost of delivering routine vaccinations at GP practices in England? A comparative time-driven activity-based costing analysis. Hum Vaccin Immunother., 1-8.
Paterson P, Mounier-Jack S, Saliba V, Yarwood J, White J, Ramsay M, Chantler T. 2019 Jun 20. Strengthening HPV vaccination delivery: findings from a qualitative service evaluation of the adolescent girls' HPV vaccination programme in England. J Public Health (Oxf), pii: fdz061.
Luyten J, Kessels R, Atkins KE, Jit M, van Hoek AJ. 2019 May. Quantifying the public's view on social value judgments in vaccine decision-making: A discretechoice experiment.. Social Science and Medicine, 228:181-193.